Non-coding RNAs in saliva: Emerging biomarkers for molecular diagnostics

International Journal of Molecular Sciences

Volumn 16, Issue 4, 2015, Pages 8676-8698

  Majem, Blanca ^a   Rigau, Marina ^a   Reventós, Jaume ^a,b   Wong, David T ^c  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Biomarkers; Body fluid; Diagnostics; Disease; Liquid biopsy; Long ncRNAs; Non coding RNA (ncRNAs); Non invasiveness; Saliva; Small ncRNAs

Indexed keywords

BIOLOGICAL MARKER; MESSENGER RNA; RIBONUCLEASE; UNTRANSLATED RNA;

CARCINOGENESIS; GENE EXPRESSION; HUMAN; LYMPH NODE METASTASIS; MOLECULAR DIAGNOSTICS; MOLECULAR PATHOLOGY; NEOPLASM; QUANTITATIVE ASSAY; REGULATORY MECHANISM; REGULATORY RNA SEQUENCE; REVIEW; SALIVA ANALYSIS; TUMOR GROWTH; ANIMAL; GENETICS; METABOLISM; MOLECULAR DIAGNOSIS; SALIVA; SEQUENCE ANALYSIS;

ANIMALS; BIOMARKERS; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; RNA, UNTRANSLATED; SALIVA; SEQUENCE ANALYSIS, RNA;

EID: 84928103113     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms16048676     Document Type: Review

References (120)

1. Loo, J.A.; Yan, W.; Ramachandran, P.; Wong, D.T. Comparative human salivary and plasma proteomes. J. Dent. Res. 2010, 89, 1016–1023.
2. Yan, W.; Apweiler, R.; Balgley, B.M.; Boontheung, P.; Bundy, J.L.; Cargile, B.J.; Cole, S.; Fang, X.; Gonzalez-Begne, M.; Griffin, T.J., et al. Systematic comparison of the human saliva and plasma proteomes. Proteomics Clin. Appl. 2009, 3, 116–134.
3. Mandel, I.D. The role of saliva in maintaining oral homeostasis. J. Am. Dent. Assoc. 1989, 119, 298–304.
4. Amerongen, A.V.N.; Veerman, E.C.I. Saliva—The defender of the oral cavity. Oral Dis. 2002, 8, 12–22.
5. Teshima, K.; Murakami, R.; Tomitaka, E.; Nomura, T.; Toya, R.; Hiraki, A.; Nakayama, H.; Hirai, T.; Shinohara, M.; Oya, N., et al. Radiation-induced parotid gland changes in oral cancer patients: Correlation between parotid volume and saliva production. Jpn. J. Clin. Oncol. 2010, 40, 42–46.
6. Lee, Y.H.; Wong, D.T. Saliva: An emerging biofluid for early detection of diseases. Am. J. Dent. 2009, 22, 241–248.
7. Baum, B.J.; Yates, J.R.; Srivastava, S.; Wong, D.T.W.; Melvin, J.E. Scientific frontiers: Emerging technologies for salivary diagnostics. Adv. Dent. Res. 2011, 23, 360–368.
8. Segal, A.; Wong, D.T. Salivary diagnostics: Enhancing disease detection and making medicine better. Eur. J. Dent. Educ. 2008, 12, 22–29.
9. Hu, S.; Li, Y.; Wang, J.; Xie, Y.; Tjon, K.; Wolinsky, L.; Loo, R.R.O.; Loo, J.A.; Wong, D.T. Human saliva proteome and transcriptome. J. Dent. Res. 2006, 85, 1129–1133.
10. Ramachandran, P.; Boontheung, P.; Xie, Y.; Sondej, M.; Wong, D.T.; Loo, J.A. Identification of N-linked glycoproteins in human saliva by glycoprotein capture and mass spectrometry. J. Proteome Res. 2006, 5, 1493–1503.
11. Whitelegge, J.P.; Zabrouskov, V.; Halgand, F.; Souda, P.; Bassilian, S.; Yan, W.; Wolinsky, L.; Loo, J.A.; Wong, D.T.W.; Faull, K.F. Protein-sequence polymorphisms and post-translational modifications in proteins from human saliva using top–down fourier-transform ion cyclotron resonance mass spectrometry. Int. J. Mass Spectrom. 2007, 268, 190–197.
12. Sondej, M.; Denny, P.A.; Xie, Y.; Ramachandran, P.; Si, Y.; Takashima, J.; Shi, W.; Wong, D.T.; Loo, J.A.; Denny, P.C. Glycoprofiling of the human salivary proteome. Clin. Proteomics 2009, 5, 52–68.
13. Hu, S.; Jiang, J.; Wong, D.T. Proteomic analysis of saliva: 2D gel electrophoresis, LC–MS/MS, and Western blotting. Methods Mol. Biol. 2010, 666, 31–41.
14. Halgand, F.; Zabrouskov, V.; Bassilian, S.; Souda, P.; Loo, J.A.; Faull, K.F.; Wong, D.T.; Whitelegge, J.P. Defining intact protein primary structures from saliva: A step toward the human proteome project. Anal. Chem. 2012, 84, 4383–4395.
15. Li, Y.; Zhou, X.; St John, M.A.R.; Wong, D.T.W. RNA profiling of cell-free saliva using microarray technology. J. Dent. Res. 2004, 83, 199–203.
16. Park, N.J.; Li, Y.; Yu, T.; Brinkman, B.M.N.; Wong, D.T. Characterization of RNA in saliva. Clin. Chem. 2006, 52, 988–994.
17. Park, N.J.; Zhou, X.; Yu, T.; Brinkman, B.M.N.; Zimmermann, B.G.; Palanisamy, V.; Wong, D.T. Characterization of salivary RNA by cDNA library analysis. Arch. Oral Biol. 2007, 52, 30–35.
18. Hu, Z.; Zimmermann, B.G.; Zhou, H.; Wang, J.; Henson, B.S.; Yu, W.; Elashoff, D.; Krupp, G.; Wong, D.T. Exon-level expression profiling: A comprehensive transcriptome analysis of oral fluids. Clin. Chem. 2008, 54, 824–832.
19. Wei, F.; Wang, J.; Liao, W.; Zimmermann, B.G.; Wong, D.T.; Ho, C.M. Electrochemical detection of low-copy number salivary RNA based on specific signal amplification with a hairpin probe. Nucleic Acids Res. 2008, 36, e65.
20. Palanisamy, V.; Wong, D.T. Transcriptomic analyses of saliva. Methods Mol. Biol. 2010, 666, 43–51.
21. Spielmann, N.; Ilsley, D.; Gu, J.; Lea, K.; Brockman, J.; Heater, S.; Setterquist, R.; Wong, D.T.W. The human salivary RNA transcriptome revealed by massively parallel sequencing. Clin. Chem. 2012, 58, 1314–1321.
22. Farrell, J.J.; Zhang, L.; Zhou, H.; Chia, D.; Elashoff, D.; Akin, D.; Paster, B.J.; Joshipura, K.; Wong, D.T.W. Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer. Gut 2012, 61, 582–588.
23. Sugimoto, M.; Wong, D.T.; Hirayama, A.; Soga, T.; Tomita, M. Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles. Metabolomics 2010, 6, 78–95.
24. Shankar, A.A.; Alex, S.; Routray, S. Incorporation of salivary metabolomics in oral cancer diagnostics. Oral Oncol. 2014, 50, e53–e54.
25. Barnes, V.M.; Kennedy, A.D.; Panagakos, F.; Devizio, W.; Trivedi, H.M.; Jönsson, T.; Guo, L.; Cervi, S.; Scannapieco, F.A. Global metabolomic analysis of human saliva and plasma from healthy and diabetic subjects, with and without periodontal disease. PLoS ONE 2014, 9, e105181.
26. Salivaomics Knowledge Base. Available online: http//www.skb.ucla.edu (accessed on 23 July 2010).
27. Ai, J.; Smith, B.; Wong, D.T. Saliva ontology: An ontology-based framework for a salivaomics knowledge base. BMC Bioinform. 2010, 11, 302.
28. Wong, D.T.W. Salivaomics. J. Am. Dent. Assoc. 2012, 143, S19–S24.
29. Navazesh, M. Methods for collecting saliva. Ann. N. Y. Acad. Sci. 1993, 694, 72–77.
30. Henson, B.S.; Wong, D.T. Collection, storage, and processing of saliva samples for downstream molecular applications. Methods Mol. Biol. 2010, 666, 21–30.
31. Lee, Y.H.; Zhou, H.; Reiss, J.K.; Yan, X.; Zhang, L.; Chia, D.; Wong, D.T.W. Direct saliva transcriptome analysis. Clin. Chem. 2011, 57, 1295–1302.
32. Park, N.J.; Yu, T.; Nabili, V.; Brinkman, B.M.N.; Henry, S.; Wang, J.; Wong, D.T. RNAprotect saliva: An optimal room-temperature stabilization reagent for the salivary transcriptome. Clin. Chem. 2006, 52, 2303–2304.
33. Jiang, J.; Park, N.J.; Hu, S.; Wong, D.T. A universal pre-analytic solution for concurrent stabilization of salivary proteins, RNA and DNA at ambient temperature. Arch. Oral Biol. 2009, 54, 268–273.
34. Kim, J.K.; Zhou, H.; Nabili, V.; Wang, M.B.; Abemayor, E.; Wong, D.T.W. Utility of multiple sampling in reducing variation of salivary interleukin-8 and interleukin-1β mRNA levels in healthy adults. Head Neck 2013, 35, 968–973.
35. Xiao, H.; Wong, D.T.W. Method development for proteome stabilization in human saliva. Anal. Chim. Acta 2012, 722, 63–69.
36. Hu, S.; Wang, J.; Meijer, J.; Ieong, S.; Xie, Y.; Yu, T.; Zhou, H.; Henry, S.; Vissink, A.; Pijpe, J., et al. Salivary proteomic and genomic biomarkers for primary Sjögren’s syndrome. Arthritis Rheumatol. 2007, 56, 3588–3600.
37. Hu, S.; Gao, K.; Pollard, R.; Arellano-Garcia, M.; Zhou, H.; Zhang, L.; Elashoff, D.; Kallenberg, C.G.M.; Vissink, A.; Wong, D.T. Preclinical validation of salivary biomarkers for primary Sjögren’s syndrome. Arthritis Care Res. (Hoboken) 2010, 62, 1633–1638.
38. Hu, S.; Vissink, A.; Arellano, M.; Roozendaal, C.; Zhou, H.; Kallenberg, C.G.M.; Wong, D.T. Identification of autoantibody biomarkers for primary Sjögren’s syndrome using protein microarrays. Proteomics 2011, 11, 1499–1507.
39. St John, M.A.R.; Li, Y.; Zhou, X.; Denny, P.; Ho, C.M.; Montemagno, C.; Shi, W.; Qi, F.; Wu, B.; Sinha, U., et al. Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma. Arch. Otolaryngol. Head Neck Surg. 2004, 130, 929–935.
40. Li, Y.; St John, M.A.R.; Zhou, X.; Kim, Y.; Sinha, U.; Jordan, R.C.K.; Eisele, D.; Abemayor, E.; Elashoff, D.; Park, N.H., et al. Salivary transcriptome diagnostics for oral cancer detection. Clin. Cancer Res. 2004, 10, 8442–8450.
41. Arellano-Garcia, M.E.; Hu, S.; Wang, J.; Henson, B.; Zhou, H.; Chia, D.; Wong, D.T. Multiplexed immunobead-based assay for detection of oral cancer protein biomarkers in saliva. Oral Dis. 2008, 14, 705–712.
42. Hu, S.; Arellano, M.; Boontheung, P.; Wang, J.; Zhou, H.; Jiang, J.; Elashoff, D.; Wei, R.; Loo, J.A.; Wong, D.T. Salivary proteomics for oral cancer biomarker discovery. Clin. Cancer Res. 2008, 14, 6246–6252.
43. Elashoff, D.; Zhou, H.; Reiss, J.; Wang, J.; Xiao, H.; Henson, B.; Hu, S.; Arellano, M.; Sinha, U.; Le, A., et al. Prevalidation of salivary biomarkers for oral cancer detection. Cancer Epidemiol. Biomark. Prev. 2012, 21, 664–672.
44. Tamashiro, H.; Constantine, N.T. Serological diagnosis of HIV infection using oral fluid samples. Bull. World Health Organ. 1994, 72, 135–143.
45. Mortimer, P.P.; Parry, J. V Detection of antibody to HIV in saliva: A brief review. Clin. Diagn. Virol. 1994, 2, 231–243.
46. Hodinka, R.L.; Nagashunmugam, T.; Malamud, D. Detection of human immunodeficiency virus antibodies in oral fluids. Clin. Diagn. Lab. Immunol. 1998, 5, 419–426.
47. Yaari, A.; Tovbin, D.; Zlotnick, M.; Mostoslavsky, M.; Shemer-Avni, Y.; Hanuka, N.; Burbea, Z.; Katzir, Z.; Storch, S.; Margalith, M. Detection of HCV salivary antibodies by a simple and rapid test. J. Virol. Methods 2006, 133, 1–5.
48. Elsana, S.; Sikuler, E.; Yaari, A.; Shemer-Avni, Y.; Abu-Shakra, M.; Buskila, D.; Katzman, P.; Naggan, L.; Margalith, M. HCV antibodies in saliva and urine. J. Med. Virol. 1998, 55, 24–27.
49. Cha, Y.J.; Park, Q.; Kang, E.S.; Yoo, B.C.; Park, K.U.; Kim, J.W.; Hwang, Y.S.; Kim, M.H. Performance evaluation of the OraQuick hepatitis C virus rapid antibody test. Ann. Lab. Med. 2013, 33, 184–189.
50. Sosa-Jurado, F.; Hernández-Galindo, V.L.; Meléndez-Mena, D.; Mendoza-Torres, M.A.; Martínez-Arroniz, F.J.; Vallejo-Ruiz, V.; Reyes-Leyva, J.; Santos-López, G. Detection of hepatitis C virus RNA in saliva of patients with active infection not associated with periodontal or liver disease severity. BMC Infect. Dis. 2014, 14, 72.
51. Rao, P.V; Reddy, A.P.; Lu, X.; Dasari, S.; Krishnaprasad, A.; Biggs, E.; Roberts, C.T.; Nagalla, S.R. Proteomic identification of salivary biomarkers of type-2 diabetes. J. Proteome Res. 2009, 8, 239–245.
52. Desai, G.S.; Mathews, S.T. Saliva as a non-invasive diagnostic tool for inflammation and insulin-resistance. World J. Diabetes 2014, 5, 730–738.
53. Lu, L.; Mackay, D.F.; Newby, D.E.; Pell, J.P. Association between salivary cotinine and cardiovascular biomarkers among nonsmokers and current smokers: Cross-sectional study of 10,081 participants. Eur. J. Vasc. Endovasc. Surg. 2014, 48, 703–710.
54. Zheng, H.; Li, R.; Zhang, J.; Zhou, S.; Ma, Q.; Zhou, Y.; Chen, F.; Lin, J. Salivary biomarkers indicate obstructive sleep apnea patients with cardiovascular diseases. Sci. Rep. 2014, 4, 7046, doi:10.1038/srep07046.
55. Gao, K.; Zhou, H.; Zhang, L.; Lee, J.W.; Zhou, Q.; Hu, S.; Wolinsky, L.E.; Farrell, J.; Eibl, G.; Wong, D.T. Systemic disease-induced salivary biomarker profiles in mouse models of melanoma and non-small cell lung cancer. PLoS ONE 2009, 4, e5875.
56. Xiao, H.; Zhang, L.; Zhou, H.; Lee, J.M.; Garon, E.B.; Wong, D.T.W. Proteomic analysis of human saliva from lung cancer patients using two-dimensional difference gel electrophoresis and mass spectrometry. Mol. Cell. Proteomics 2012, 11, M111.012112.
57. Zhang, L.; Xiao, H.; Zhou, H.; Santiago, S.; Lee, J.M.; Garon, E.B.; Yang, J.; Brinkmann, O.; Yan, X.; Akin, D., et al. Development of transcriptomic biomarker signature in human saliva to detect lung cancer. Cell. Mol. Life Sci. 2012, 69, 3341–3350.
58. Zhang, L.; Farrell, J.J.; Zhou, H.; Elashoff, D.; Akin, D.; Park, N.H.; Chia, D.; Wong, D.T. Salivary transcriptomic biomarkers for detection of resectable pancreatic cancer. Gastroenterology 2010, 138, 949–957.e7.
59. Lau, C.; Kim, Y.; Chia, D.; Spielmann, N.; Eibl, G.; Elashoff, D.; Wei, F.; Lin, Y.L.; Moro, A.; Grogan, T., et al. Role of pancreatic cancer-derived exosomes in salivary biomarker development. J. Biol. Chem. 2013, 288, 26888–26897.
60. Brooks, M.N.; Wang, J.; Li, Y.; Zhang, R.; Elashoff, D.; Wong, D.T. Salivary protein factors are elevated in breast cancer patients. Mol. Med. Rep. 2008, 1, 375–378.
61. Zhang, L.; Xiao, H.; Karlan, S.; Zhou, H.; Gross, J.; Elashoff, D.; Akin, D.; Yan, X.; Chia, D.; Karlan, B., et al. Discovery and preclinical validation of salivary transcriptomic and proteomic biomarkers for the non-invasive detection of breast cancer. PLoS ONE 2010, 5, e15573.
62. Lee, Y.H.; Kim, J.H.; Zhou, H.; Kim, B.W.; Wong, D.T. Salivary transcriptomic biomarkers for detection of ovarian cancer: For serous papillary adenocarcinoma. J. Mol. Med. 2012, 90, 427–434.
63. Mattick, J.S. Non-coding RNAs: The architects of eukaryotic complexity. EMBO Rep. 2001, 2, 986–991.
64. Morris, K.V.; Mattick, J.S. The rise of regulatory RNA. Nat. Rev. Genet. 2014, 15, 423–437.
65. Orozco, A.F.; Lewis, D.E. Flow cytometric analysis of circulating microparticles in plasma. Cytometry A 2010, 77, 502–514.
66. Brosnan, C.A.; Voinnet, O. The long and the short of noncoding RNAs. Curr. Opin. Cell Biol. 2009, 21, 416–425.
67. Esteller, M. Non-coding RNAs in human disease. Nat. Rev. Genet. 2011, 12, 861–874.
68. Reis, E.M.; Verjovski-Almeida, S. Perspectives of long non-coding RNAs in cancer diagnostics. Front. Genet. 2012, 3, 32.
69. Mercer, T.R.; Dinger, M.E.; Mattick, J.S. Long non-coding RNAs: Insights into functions. Nat. Rev. Genet. 2009, 10, 155–159.
70. Dalmay, T. MicroRNAs and cancer. J. Intern. Med. 2008, 263, 366–375.
71. Tandon, M.; Gallo, A.; Jang, S.I.; Illei, G.G.; Alevizos, I. Deep sequencing of short RNAs reveals novel microRNAs in minor salivary glands of patients with Sjögren’s syndrome. Oral Dis. 2012, 18, 127–131.
72. Ogawa, Y.; Taketomi, Y.; Murakami, M.; Tsujimoto, M.; Yanoshita, R. Small RNA transcriptomes of two types of exosomes in human whole saliva determined by next generation sequencing. Biol. Pharm. Bull. 2013, 36, 66–75.
73. Bahn, J.H.; Zhang, Q.; Li, F.; Chan, T.M.; Lin, X.; Kim, Y.; Wong, D.T.W.; Xiao, X. The landscape of microRNA, Piwi-interacting RNA, and circular RNA in human saliva. Clin. Chem. 2015, 61, 221–230.
74. Michael, A.; Bajracharya, S.D.; Yuen, P.S.T.; Zhou, H.; Star, R.A; Illei, G.G.; Alevizos, I. Exosomes from human saliva as a source of microRNA biomarkers. Oral Dis. 2010, 16, 34–38.
75. Nelson, P.; Kiriakidou, M.; Sharma, A.; Maniataki, E.; Mourelatos, Z. The microRNA world: Small is mighty. Trends Biochem. Sci. 2003, 28, 534–540.
76. Weber, J.A.; Baxter, D.H.; Zhang, S.; Huang, D.Y.; Huang, K.H.; Lee, M.J.; Galas, D.J.; Wang, K. The microRNA spectrum in 12 body fluids. Clin. Chem. 2010, 56, 1733–1741.
77. Patel, R.S.; Jakymiw, A.; Yao, B.; Pauley, B.A.; Carcamo, W.C.; Katz, J.; Cheng, J.Q.; Chan, E.K.L. High resolution of microRNA signatures in human whole saliva. Arch. Oral Biol. 2011, 56, 1506–1513.
78. Park, N.J.; Zhou, H.; Elashoff, D.; Henson, B.S.; Kastratovic, D.A.; Abemayor, E.; Wong, D.T. Salivary microRNA: Discovery, characterization, and clinical utility for oral cancer detection. Clin. Cancer Res. 2009, 15, 5473–5477.
79. Hanson, E.K.; Lubenow, H.; Ballantyne, J. Identification of forensically relevant body fluids using a panel of differentially expressed microRNAs. Anal. Biochem. 2009, 387, 303–314.
80. Théry, C.; Zitvogel, L.; Amigorena, S. Exosomes: Composition, biogenesis and function. Nat. Rev. Immunol. 2002, 2, 569–579.
81. Valadi, H.; Ekström, K.; Bossios, A.; Sjöstrand, M.; Lee, J.J.; Lötvall, J.O. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 2007, 9, 654–659.
82. Vlassov, A.V.; Magdaleno, S.; Setterquist, R.; Conrad, R. Exosomes: Current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. Biochim. Biophys. Acta Gen. Subj. 2012, 1820, 940–948.
83. Pisitkun, T.; Shen, R.; Knepper, M.A. Identification and proteomic profiling of exosomes in human urine. Proc. Natl. Acad. Sci. USA 2004, 101, 13368–13373.
84. Lässer, C.; Alikhani, V.S.; Ekström, K.; Eldh, M.; Paredes, P.T.; Bossios, A.; Sjöstrand, M.; Gabrielsson, S.; Lötvall, J.; Valadi, H. Human saliva, plasma and breast milk exosomes contain RNA: Uptake by macrophages. J. Transl. Med. 2011, 9, 9, doi:10.1186/1479-5876-9-9.
85. Mittelbrunn, M.; Gutiérrez-Vázquez, C.; Villarroya-Beltri, C.; González, S.; Sánchez-Cabo, F.; González, M.Á.; Bernad, A.; Sánchez-Madrid, F. Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells. Nat. Commun. 2011, 2, doi:10.1038/ncomms1285.
86. Berckmans, R.J.; Sturk, A.; van Tienen, L.M.; Schaap, M.C.L.; Nieuwland, R. Cell-derived vesicles exposing coagulant tissue factor in saliva. Blood 2011, 117, 3172–3180.
87. Ogawa, Y.; Miura, Y.; Harazono, A.; Kanai-Azuma, M.; Akimoto, Y.; Kawakami, H.; Yamaguchi, T.; Toda, T.; Endo, T.; Tsubuki, M., et al. Proteomic analysis of two types of exosomes in human whole saliva. Biol. Pharm. Bull. 2011, 34, 13–23.
88. Palanisamy, V.; Sharma, S.; Deshpande, A.; Zhou, H.; Gimzewski, J.; Wong, D.T. Nanostructural and transcriptomic analyses of human saliva derived exosomes. PLoS ONE 2010, 5, e8577.
89. Sharma, S.; Rasool, H.I.; Palanisamy, V.; Mathisen, C.; Schmidt, M.; Wong, D.T.; Gimzewski, J.K. Structural-mechanical characterization of nanoparticle exosomes in human saliva, using correlative AFM, FESEM, and force spectroscopy. ACS Nano 2010, 4, 1921–1926.
90. Xiao, H.; Wong, D.T.W. Proteomic analysis of microvesicles in human saliva by gel electrophoresis with liquid chromatography–mass spectrometry. Anal. Chim. Acta 2012, 723, 61–67.
91. Gallo, A.; Tandon, M.; Alevizos, I.; Illei, G.G. The majority of microRNAs detectable in serum and saliva is concentrated in exosomes. PLoS ONE 2012, 7, e30679.
92. Boja, E.; Hiltke, T.; Rivers, R.; Kinsinger, C.; Rahbar, A.; Mesri, M.; Rodriguez, H. Evolution of clinical proteomics and its role in medicine. J. Proteome Res. 2011, 10, 66–84.
93. Wiklund, E.D.; Gao, S.; Hulf, T.; Sibbritt, T.; Nair, S.; Costea, D.E.; Villadsen, S.B.; Bakholdt, V.; Bramsen, J.B.; Sørensen, J.A., et al. MicroRNA alterations and associated aberrant DNA methylation patterns across multiple sample types in oral squamous cell carcinoma. PLoS ONE 2011, 6, e27840.
94. Liu, C.J.; Lin, S.C.; Yang, C.C.; Cheng, H.W.; Chang, K.W. Exploiting salivary miR-31 as a clinical biomarker of oral squamous cell carcinoma. Head Neck 2012, 34, 219–224.
95. Matse, J.H.; Yoshizawa, J.; Wang, X.; Elashoff, D.; Bolscher, J.G.M.; Veerman, E.C.I.; Bloemena, E.; Wong, D.T.W. Discovery and prevalidation of salivary extracellular microRNA biomarkers panel for the noninvasive detection of benign and malignant parotid gland tumors. Clin. Cancer Res. 2013, 19, 3032–3038.
96. Tang, H.; Wu, Z.; Zhang, J.; Su, B. Salivary lncRNA as a potential marker for oral squamous cell carcinoma diagnosis. Mol. Med. Rep. 2013, 7, 761–766.
97. Wang, Z.; Zhang, J.; Guo, Y.; Wu, X.; Yang, W.; Xu, L.; Chen, J.; Fu, F. A novel electrically magnetic-controllable electrochemical biosensor for the ultra sensitive and specific detection of attomolar level oral cancer-related microRNA. Biosens. Bioelectron. 2013, 45, 108–113.
98. Xie, Z.; Chen, G.; Zhang, X.; Li, D.; Huang, J.; Yang, C.; Zhang, P.; Qin, Y.; Duan, Y.; Gong, B.; Li, Z. Salivary microRNAs as promising biomarkers for detection of esophageal cancer. PLoS ONE 2013, 8, e57502.
99. Yang, Y.; Li, Y.; Yang, X.; Jiang, L.; Zhou, Z.; Zhu, Y. Progress risk assessment of oral premalignant lesions with saliva miRNA analysis. BMC Cancer 2013, 13, 129.
100. Salazar, C.; Nagadia, R.; Pandit, P.; Cooper-White, J.; Banerjee, N.; Dimitrova, N.; Coman, W.B.; Punyadeera, C. A novel saliva-based microRNA biomarker panel to detect head and neck cancers. Cell. Oncol. 2014, 37, 331–338.
101. Wang, Y.; Wang, Q.; Zhang, N.; Ma, H.; Gu, Y.; Tang, H.; Xu, Z.; Gao, Y. Identification of microRNAs as novel biomarkers for detecting esophageal squamous cell carcinoma in Asians: A meta-analysis. Tumour Biol. 2014, 35, 11595–11604.
102. Momen-Heravi, F.; Trachtenberg, A.J.; Kuo, W.P.; Cheng, Y.S. Genomewide study of salivary microRNAs for detection of oral cancer. J. Dent. Res. 2014, 93, S86–S93.
103. Hizir, M.S.; Balcioglu, M.; Rana, M.; Robertson, N.M.; Yigit, M.V. Simultaneous detection of circulating oncomiRs from body fluids for prostate cancer staging using nanographene oxide. ACS Appl. Mater. Interfaces 2014, 6, 14772–14778.
104. Gao, S.; Chen, L.Y.; Wang, P.; Liu, L.M.; Chen, Z. MicroRNA expression in salivary supernatant of patients with pancreatic cancer and its relationship with Zheng. Biomed Res. Int. 2014, 2014, 1–8.
105. Zubakov, D.; Boersma, A.W.M.; Choi, Y.; van Kuijk, P.F.; Wiemer, E.A.C.; Kayser, M. MicroRNA markers for forensic body fluid identification obtained from microarray screening and quantitative RT-PCR confirmation. Int. J. Legal Med. 2010, 124, 217–226.
106. Courts, C.; Madea, B. Specific micro-RNA signatures for the detection of saliva and blood in forensic body-fluid identification. J. Forensic Sci. 2011, 56, 1464–1470.
107. Wang, Z.; Luo, H.; Pan, X.; Liao, M.; Hou, Y. A model for data analysis of microRNA expression in forensic body fluid identification. Forensic Sci. Int. Genet. 2012, 6, 419–423.
108. Omelia, E.J.; Uchimoto, M.L.; Williams, G. Quantitative PCR analysis of blood- and saliva-specific microRNA markers following solid-phase DNA extraction. Anal. Biochem. 2013, 435, 120–122.
109. Park, J.L.; Park, S.M.; Kwon, O.H.; Lee, H.; Kim, J.; Seok, H.H.; Lee, W.S.; Lee, S.H.; Kim, Y.S.; Woo, K.M., et al. Microarray screening and qRT-PCR evaluation of microRNA markers for forensic body fluid identification. Electrophoresis 2014, 35, 3062–3068.
110. Silva, S.S.; Lopes, C.; Teixeira, A.L.; de Sousa, M.J.C.; Medeiros, R. Forensic miRNA: Potential biomarker for body fluids? Forensic Sci. Int. Genet. 2015, 14C, 1–10.
111. NanoString nCounter® miRNA Expression Assays. Available online: http://www.nanostring.com/products/miRNA (accessed on 19 April 2010).
112. Wu, W.; Hou, W.; Wu, Z.; Wang, Y.; Yi, Y.; Lin, W. miRNA-144 in the saliva is a genetic marker for early diagnosis of esophageal cancer. Nan Fang Yi Ke Da Xue Xue Bao 2013, 33, 1783–1786.
113. Isin, M.; Ozgur, E.; Cetin, G.; Erten, N.; Aktan, M.; Gezer, U.; Dalay, N. Investigation of circulating lncRNAs in B-cell neoplasms. Clin. Chim. Acta 2014, 431, 255–259.
114. Ren, S.; Wang, F.; Shen, J.; Sun, Y.; Xu, W.; Lu, J.; Wei, M.; Xu, C.; Wu, C.; Zhang, Z., et al. Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 derived miniRNA as a novel plasma-based biomarker for diagnosing prostate cancer. Eur. J. Cancer 2013, 49, 2949–2959.
115. Rönnau, C.G.H.; Verhaegh, G.W.; Luna-Velez, M.V.; Schalken, J.A. Noncoding RNAs as novel biomarkers in prostate cancer. Biomed Res. Int. 2014, 2014, doi:10.1155/2014/591703.
116. Kohls, K.; Schmidt, D.; Holdenrieder, S.; Müller, S.C.; Ellinger, J. Detection of cell-free lncRNA in serum of cancer patients. Urol. A 2014, doi:10.1007/s00120-014-3655-5.
117. Juusola, J.; Ballantyne, J. Messenger RNA profiling: A prototype method to supplant conventional methods for body fluid identification. Forensic Sci. Int. 2003, 135, 85–96.
118. Juusola, J.; Ballantyne, J. Multiplex mRNA profiling for the identification of body fluids. Forensic Sci. Int. 2005, 152, 1–12.
119. Alvarez, M.; Ballantyne, J. The identification of newborns using messenger RNA profiling analysis. Anal. Biochem. 2006, 357, 21–34.
120. Zhang, Y.; Sun, J.; Lin, C.C.; Abemayor, E.; Wang, M.B.; Wong, D.T.W. The emerging landscape of salivary diagnostics. Oral Health Dent. Manag. 2014, 13, 200–210.